制备含抛射剂四氟乙烷的丙酸倍氯米松吸入气雾剂

张雯, 李兆明, 王金虎, 李尚宾

中国药学杂志 ›› 2019, Vol. 54 ›› Issue (7) : 571-575.

PDF(1022 KB)
PDF(1022 KB)
中国药学杂志 ›› 2019, Vol. 54 ›› Issue (7) : 571-575. DOI: 10.11669/cpj.2019.07.009
·论 著·

制备含抛射剂四氟乙烷的丙酸倍氯米松吸入气雾剂

  • 张雯, 李兆明, 王金虎, 李尚宾
作者信息 +

Preparation of Beclometasone Dipropionate Inhalation Aerosol Containing Tetrafluoroethane as the Propellant

  • ZHANGWen, LIZhao-ming, WANGJin-hu, LIShang-bin
Author information +
文章历史 +

摘要

目的 制备以四氟乙烷作为抛射剂的丙酸倍氯米松吸入气雾剂。方法 采用析因设计,以微细粒子剂量作为主要评价指标进行处方筛选,以微细粒子剂量、每揿主药含量及递送剂量均一性作为关键质量指标进行最优处方验证,并在此基础上筛选出合适的驱动器。结果 所选处方工艺制得的3批样品搭配Becotide®驱动器测得的微细粒子剂量均值为33.1%,每揿主药含量在98.3%~100.7%,递送剂量均一性在87%~118%,与Becotide®相当,微细粒子剂量测定结果与预测值32.9%接近,表明采用析因设计筛选处方及通过模型预测最优值是可靠的。自制样品搭配驱动器B测得的微细粒子剂量、质量中值空气动力学直径、几何标准差与Becotide®最接近,同时,每揿主药含量及递送剂量均一性结果均符合规定,因此选择驱动器B作为本品配套的驱动器。结论 所选处方工艺稳定可靠,适合生产,成品宜配置驱动器B。

Abstract

OBJECTIVE To prepare the beclometasone dipropionate inhalation aerosol using tetrafluoroethane as the propellant.METHODS Using the factorial design, the fine particle fraction was used as the main evaluation index to screen prescriptions; the fine particle fraction, delivered dose and uniformity of delivered dose were used as the critical quality indexes to verify the optimal prescription, and on this basis, the appropriate actuator was screened out. RESULTS The average value of fine particle fraction, the range of delivered dose and uniformity of delivered dose resulted from three batches of aerosol produced by the preferable prescription and process with the actuator of Becotide® were 33.1%, 98.3%-100.7%, and 87%-118%, which was comparable to Becotide®, and the measured result of fine particle fraction was close to the predicted value of 32.9% by Design-Expert 8.0, indicating that to screen prescriptions by using factorial design and predict the optimal value through the model were reliable. The results of fine particle fraction, mass median aerodynamic diameter and geometric standard deviation measured by the self-made products with actuator B were the closest to Becotide®. Meanwhile, the results of delivered dose and uniformity of delivered dose were all in compliance with the requirement. Therefore, actuator B was selected as the matched actuator of this product. CONCLUTION The selected prescription and process are stable, reliable, and suitable for production, the final product should be configured with the actuator B.

关键词

丙酸倍氯米松 / 气雾剂 / 四氟乙烷 / 驱动器 / 抛射剂

Key words

beclometasone dipropionate / aerosol / tetrafluoroethane / actuator / propellant

引用本文

导出引用
张雯, 李兆明, 王金虎, 李尚宾. 制备含抛射剂四氟乙烷的丙酸倍氯米松吸入气雾剂[J]. 中国药学杂志, 2019, 54(7): 571-575 https://doi.org/10.11669/cpj.2019.07.009
ZHANGWen, LIZhao-ming, WANGJin-hu, LIShang-bin. Preparation of Beclometasone Dipropionate Inhalation Aerosol Containing Tetrafluoroethane as the Propellant[J]. Chinese Pharmaceutical Journal, 2019, 54(7): 571-575 https://doi.org/10.11669/cpj.2019.07.009
中图分类号: R944   

参考文献

[1] MA X Y, FAN Y, JIN F. Advances of formulation optimization techniques in pressurized metered dose inhalers[J]. Chin J Pharm(中国医药工业杂志), 2014, 45(2):167-173.
[2] LEI B K, JIN F. Progress of freon propellant replacement in metered dose inhaler [J]. Chin J Pharm(中国医药工业杂志), 2007, 38(6):447-451.
[3] CHEN B L, GAO C L, LI L, et al. Determination methods for in vitro deposition of metered dose inhalers:differences of three impactors[J]. J Int Pharm Res(国际药学研究杂志), 2016, 43(5):961-970.
[4] YAN C X, WANG L D, CHEN G L. Next generation pharmaceutical impactor and its application[J]. Chin J Pharm Anal(药物分析杂志), 2009, 29(9):1572-1578.
[5] REN J L, TIAN L Q, CHEN L, et al. Optimization of sub-coating formulation of rabeprazole sodium enteric-coated tablets by factorial design[J]. Cent South Pharm(中南药学), 2017, 15(1):26-29.
[6] LEI H Y. Study on determination method of assay of beclomethasone propionate aerosol[J]. Medicine(医药), 2015,(16):90.
[7] ZHENG L X, WANG C C, SHAO H, et al. Determination of the content per actuation of ribavirin aerosol by DUSA method[J]. Chin J Pharm(中国医药工业杂志), 2013, 44(10):1021-1024.
[8] WANG Z J, LI H Y, LUAN H S,et al. Comparison of the Aerosol dosage from the valve and the mouthpiece[J]. Chin J Pharm(中国医药工业杂志), 2017, 48(2):243-245.
[9] SHAO Q, WANG M J, LIAN Y F, et al. Effect of actuator on quality of pressured metered dose inhaler (pMDI) [J]. Chin J Pharm(中国医药工业杂志), 2013, 44(10):997-1000.
[10] LIU H, YIN J H, ZHOU B, et al. Effect of particle size of budesonide as active pharmaceutical ingredient and diameter of spray orifice of actuator on performance of pressured metered dose inhalers[J]. Cent South Pharm(中南药学), 2016, 14(3):246-250.
[11] WANG J S, XI L, YE W W, et al. Formulation optimization of the sustained-release layer of enalapril maleate and felodipine double-layer tablets by Plackett-Burman combined with Box-Behnken response surface methodology[J]. Chin J Pharm(中国医药工业杂志), 2017, 48(6):854-860.
[12] GENG X, YE J, ZHOU J P,et al. Leachables in metered-dose inhaler packages:research advances[J]. J Int Pharm Res(国际药学研究杂志), 2016, 43(3):461-465.
PDF(1022 KB)

Accesses

Citation

Detail

段落导航
相关文章

/